-
Tytuł:
-
Oral verapamil in the prevention of recurrent cerebral ischaemia due to post-stent vasospasm.
-
Autorzy:
-
Rastogi V; Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA.
Asaithambi G; John Nasseff Neuroscience Institute and United Hospital, Allina Health, St. Paul, MN, USA.
Patel A; Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA.
Park K; Department of Neurology, University of Florida College of Medicine, Gainesville, FL, USA.
Bidari S; Department of Radiology, University of Florida College of Medicine, Gainesville, FL, USA.
Hedna VS; Department of Neurology, University of New Mexico, Albuquerque, NM, USA.
-
Źródło:
-
Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2016 Jun; Vol. 41 (3), pp. 365-367. Date of Electronic Publication: 2016 Apr 06.
-
Typ publikacji:
-
Case Reports
-
Język:
-
English
-
Imprint Name(s):
-
Publication: Oxford : Wiley-Blackwell Pub.
Original Publication: Oxford : Blackwell Scientific Publications, c1987-
-
Contributed Indexing:
-
Keywords: calcium channel blocker; ischaemia; stent; stroke; vasospasm; verapamil
-
Entry Date(s):
-
Date Created: 20160410 Latest Revision: 20191120
-
Update Code:
-
20240104
-
DOI:
-
10.1111/jcpt.12387
-
PMID:
-
27060706
-
What Is Known and Objective: Endovascular embolization of basilar tip aneurysms (BTA) is performed to prevent rupture, but little is known regarding post-procedural vasospasm and its consequences. We relate management of post-procedural vasospasm found in cardiovascular literature on this rare post-procedural intracranial complication.
Case Description: A 52-year-old man develops ischaemic strokes after undergoing posterior cerebral artery (PCA) stent-assisted coil embolization of BTA. Work-up suggested that vasospasm was the cause of his strokes.
What Is New and Conclusion: Vasospasm after intracranial stenting may share similar pathophysiological features to coronary stenting, resulting in ischaemia. Verapamil should be considered an empiric therapy in prevention of stent-related vasospasm.
(© 2016 John Wiley & Sons Ltd.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.
